Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

NKTX


Fundamental

Company: Nkarta Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -1.48
Insider Own: 25.21%
Shs Outstand: 71.02M
Perf Week: -5.17%
Market Cap: 156.25M
Forward P/E: -
EPS next Y: -1.20
Insider Trans: -0.01%
Shs Float: 53.12M
Perf Month: 0.92%
Enterprise Value: -54.90M
PEG: -
EPS next Q: -0.30
Inst Own: 72.40%
Short Float: 16.33%
Perf Quarter: 21.55%
Income: -109.24M
P/S: -
EPS this Y: 17.59%
Inst Trans: -6.24%
Short Ratio: 16.38
Perf Half Y: 25.71%
Sales: 0.00M
P/B: 0.44
EPS next Y Percentage: 9.37%
ROA: -21.80%
Short Interest: 8.67M
Perf YTD: -11.65%
Book/sh: 5.04
P/C: 0.54
EPS next 5Y: 7.53%
ROE: -26.94%
52W High: 6.63 -66.81%
Perf Year: -61.13%
Cash/sh: 4.08
P/FCF: -
EPS past 3/5Y: 15.10% -19.86%
ROIC: -25.45%
52W Low: 1.31 67.94%
Perf 3Y: -86.27%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: -
Volatility W: 5.28%
Volatility M: 5.99%
Perf 5Y: -91.52%
Dividend TTM: -
EV/Sales: -
EPS Y/Y TTM: 26.33%
Oper. Margin: -
ATR (14): 0.13
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 15.67
Sales Y/Y TTM: -
Profit Margin: -
RSI (14): 52.87
Recom: 1.29
Dividend Gr. 3/5Y: - -
Current Ratio: 15.67
EPS Q/Q: 8.67%
SMA20: 1.03%
Beta: 0.77
Target Price: 12.40
Payout: -
Debt/Eq: 0.22
Sales Q/Q: -
SMA50: 9.82%
Rel Volume: 0.71
Prev Close: 2.24
Employees: 157
LT Debt/Eq: 0.20
Earnings: Aug 12 AMC
SMA200: 5.86%
Avg Volume: 529.40K
Price: 2.20
IPO: Jul 10, 2020
Option/Short: Yes / Yes
EPS/Sales Surpr.: 12.55% -
Trades:
Volume: 374,131
Change: -1.79%

Technical:


Latest News:

Cullinan stock rises on Amgen's Blincyto data (NASDAQ:CGEM) | Seeking Alpha very bullish
CGEM AMGN ADCT ALLO AZN AUTL BMY IPSC GILD MOR NKTX NVS

Summary: Cullinan Therapeutics (CGEM) stock surged ~58% last week after positive data for CD19-targeting therapy similar to competitor Amgen's Blincyto, showing efficacy against autoimmune diseases like rheumatoid arthritis and systemic sclerosis.

Full article
2024-04-27T19:44:12Z